This article was posted on the Pancreatic Cancer Action Network on March 9, 2018 by Allison Rosenweig, PhD. KRAS protein structure, reproduced with permission from NCI, FNLCR About 95 percent of pancreatic cancer cases – and around 30 percent of all human cancers – have a mutation in a gene called RAS. The resulting mutated … Continue reading NPR Focuses on One of the Biggest Challenges in Pancreatic Cancer: KRAS
Promising direction for the treatment of pancreatic cancers driven by KRAS mutation
University of North Carolina Lineberger Comprehensive Cancer Center researchers have found a promising strategy that may limit the growth of pancreatic cancers in patients with a mutation in a gene called KRAS. More than 95 percent of pancreatic cancers have KRAS mutations, and there's strong evidence that blocking the gene's function could be a very … Continue reading Promising direction for the treatment of pancreatic cancers driven by KRAS mutation
Der Lab 